Ovchinnikova L K, Pomortseva I V
Farmakol Toksikol. 1985 Mar-Apr;48(2):77-81.
Experiments on rabbits have demonstrated the ability of delagil to slightly increase the time of whole blood coagulation upon a single parenteral injection. On the contrary, prolonged administration of the drug per os and intramuscularly was accompanied by an insignificant enhancement of hemocoagulation. Delagil changed the effect of heparin administered after it. Heparin injection at the height of blood delagil content was accompanied by a decrease in specific activity of the anticoagulant. Prolonged administration of delagil potentiated the anticoagulation effect of heparin and prevented the development of the "return effect". In experiments made in vitro, delagil was found to be capable of inhibiting blood coagulation and forming complexes with heparin, which was accompanied by the loss of the anticoagulant activity of the latter. Interaction of the antimalarial agent with heparin in blood plasma and buffer medium is governed by exponential dependence.
对兔子的实验表明,单次非肠道注射地拉吉尔能使全血凝固时间稍有延长。相反,经口和肌肉内长期给药会使血液凝固略有增强。地拉吉尔会改变随后注射的肝素的作用。在血液中地拉吉尔含量达到峰值时注射肝素,会导致抗凝剂的比活性降低。长期给予地拉吉尔可增强肝素的抗凝作用,并防止“反跳效应”的发生。在体外实验中,发现地拉吉尔能够抑制血液凝固并与肝素形成复合物,这会导致后者抗凝活性的丧失。抗疟药与血浆和缓冲介质中的肝素之间的相互作用呈指数依赖性。